Long-term non-progressors--international study recruiting.A small fraction of people control HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. well, without needing antiretrovirals. If scientists knew how this worked, they might be able to develop entirely new treatments to enable others to do the same--possibly a major advance for individual treatment, and also for ending the epidemic epidemic, outbreak of disease that affects a much greater number of people than is usual for the locality or that spreads to regions where it is ordinarily not present. . The Elite HIV Controller Study is collecting a single blood sample from long-term nonprogressors anywhere. They will analyze the blood to look for genetic or other differences that might help explain how these people stay healthy. To be eligible, you must be from ages 18 to 75, have a viral load viral load n. The concentration of a virus, such as HIV, in the blood. viral load, n a measure of the number of virus particles present in the bloodstream, expressed as copies per milliliter. below 2000 without taking HIV medications, and give informed consent. Although the project is based at Harvard and Massachusetts General Hospital Massachusetts General Hospital Health care The major teaching hospital for Harvard Medical School, widely regarded as one of the best health care centers in the world , the blood can be drawn locally so there is no need to travel to the study site. For more information, see the study's Web page, http://www.mgh.harvard.edu/aids/hiv_elite_controllers.asp. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion